152 related articles for article (PubMed ID: 32645858)
1. Theoretical Investigations on Interactions of Arylsulphonyl Indazole Derivatives as Potential Ligands of VEGFR2 Kinase.
Czaja K; Kujawski J; Śliwa P; Kurczab R; Kujawski R; Stodolna A; Myślińska A; Bernard MK
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32645858
[TBL] [Abstract][Full Text] [Related]
2. Selected arylsulphonyl pyrazole derivatives as potential Chk1 kinase ligands-computational investigations.
Czaja K; Kujawski J; Kamel K; Bernard MK
J Mol Model; 2020 May; 26(6):144. PubMed ID: 32424505
[TBL] [Abstract][Full Text] [Related]
3. Ligand-Based Pharmacophore Modeling, Molecular Docking, and Molecular Dynamic Studies of Dual Tyrosine Kinase Inhibitor of EGFR and VEGFR2.
Sangande F; Julianti E; Tjahjono DH
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096664
[TBL] [Abstract][Full Text] [Related]
4. Molecular dynamics simulation and free energy calculation studies of kinase inhibitors binding to active and inactive conformations of VEGFR-2.
Wu X; Wan S; Wang G; Jin H; Li Z; Tian Y; Zhu Z; Zhang J
J Mol Graph Model; 2015 Mar; 56():103-12. PubMed ID: 25594497
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, biological evaluation and dynamics simulation of indazole derivatives with antiangiogenic and antiproliferative anticancer activity.
Elsayed NMY; Serya RAT; Tolba MF; Ahmed M; Barakat K; Abou El Ella DA; Abouzid KAM
Bioorg Chem; 2019 Feb; 82():340-359. PubMed ID: 30428414
[TBL] [Abstract][Full Text] [Related]
6. Discovery of octahydropyrrolo [3,2-b] pyridin derivative as a highly selective Type I inhibitor of FGFR3 over VEGFR2 by high-throughput virtual screening.
Wang X; Ye CH; Li EM; Xu LY; Lin WQ; Chen GH
J Cell Biochem; 2023 Feb; 124(2):221-238. PubMed ID: 36502529
[TBL] [Abstract][Full Text] [Related]
7. Molecular dynamics guided insight, binding free energy calculations and pharmacophore-based virtual screening for the identification of potential VEGFR2 inhibitors.
Rathi E; Kumar A; Kini SG
J Recept Signal Transduct Res; 2019; 39(5-6):415-433. PubMed ID: 31755336
[TBL] [Abstract][Full Text] [Related]
8. Exploring the Molecular Interactions of 7,8-Dihydroxyflavone and Its Derivatives with TrkB and VEGFR2 Proteins.
Chitranshi N; Gupta V; Kumar S; Graham SL
Int J Mol Sci; 2015 Sep; 16(9):21087-108. PubMed ID: 26404256
[TBL] [Abstract][Full Text] [Related]
9. Discovery of Small Molecules that Target Vascular Endothelial Growth Factor Receptor-2 Signalling Pathway Employing Molecular Modelling Studies.
Rampogu S; Baek A; Park C; Parate S; Parameswaran S; Park Y; Shaik B; Kim JH; Park SJ; Lee KW
Cells; 2019 Mar; 8(3):. PubMed ID: 30901950
[TBL] [Abstract][Full Text] [Related]
10. Exploration for novel inhibitors showing back-to-front approach against VEGFR-2 kinase domain (4AG8) employing molecular docking mechanism and molecular dynamics simulations.
Rampogu S; Baek A; Zeb A; Lee KW
BMC Cancer; 2018 Mar; 18(1):264. PubMed ID: 29514608
[TBL] [Abstract][Full Text] [Related]
11. Study on novel PtNP-sorafenib and its interaction with VEGFR2.
Liu R; Meng Y; Zhu M; Zhai H; Lv W; Wen T; Jin N
J Biochem; 2021 Oct; 170(3):411-417. PubMed ID: 33944931
[TBL] [Abstract][Full Text] [Related]
12.
Das SK; Deka SJ; Paul D; Gupta DD; Das TJ; Maravi DK; Tag H; Hui PK
J Biomol Struct Dyn; 2022 Sep; 40(15):6857-6867. PubMed ID: 33625319
[TBL] [Abstract][Full Text] [Related]
13. Exploring binding mechanisms of VEGFR2 with three drugs lenvatinib, sorafenib, and sunitinib by molecular dynamics simulation and free energy calculation.
Wang Y; Peng C; Wang G; Xu Z; Luo Y; Wang J; Zhu W
Chem Biol Drug Des; 2019 May; 93(5):934-948. PubMed ID: 30689282
[TBL] [Abstract][Full Text] [Related]
14. Binding of quinazolinones to c-KIT G-quadruplex; an interplay between hydrogen bonding and π-π stacking.
Moghaddam KG; de Vries AH; Marrink SJ; Faraji S
Biophys Chem; 2019 Oct; 253():106220. PubMed ID: 31302375
[TBL] [Abstract][Full Text] [Related]
15. The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features.
Nieminen T; Toivanen PI; Rintanen N; Heikura T; Jauhiainen S; Airenne KJ; Alitalo K; Marjomäki V; Ylä-Herttuala S
Biochim Biophys Acta; 2014 Jan; 1840(1):454-63. PubMed ID: 24112971
[TBL] [Abstract][Full Text] [Related]
16. Effect of hydrophobic and hydrogen bonding interactions on the potency of ß-alanine analogs of G-protein coupled glucagon receptor inhibitors.
Venugopal PP; Das BK; Soorya E; Chakraborty D
Proteins; 2020 Feb; 88(2):327-344. PubMed ID: 31443129
[TBL] [Abstract][Full Text] [Related]
17. Reveal the interaction mechanism of five old drugs targeting VEGFR2 through computational simulations.
Lv Y; Wang Y; Zheng X; Liang G
J Mol Graph Model; 2020 May; 96():107538. PubMed ID: 31981898
[TBL] [Abstract][Full Text] [Related]
18. Study of differences in the VEGFR2 inhibitory activities between semaxanib and SU5205 using 3D-QSAR, docking, and molecular dynamics simulations.
Muñoz C; Adasme F; Alzate-Morales JH; Vergara-Jaque A; Kniess T; Caballero J
J Mol Graph Model; 2012 Feb; 32():39-48. PubMed ID: 22070999
[TBL] [Abstract][Full Text] [Related]
19. The role of LasR active site amino acids in the interaction with the Acyl Homoserine Lactones (AHLs) analogues: A computational study.
Ahumedo Monterrosa M; Galindo JF; Vergara Lorduy J; Alí-Torres J; Vivas-Reyes R
J Mol Graph Model; 2019 Jan; 86():113-124. PubMed ID: 30352386
[TBL] [Abstract][Full Text] [Related]
20. Raddeanin A, a triterpenoid saponin isolated from Anemone raddeana, suppresses the angiogenesis and growth of human colorectal tumor by inhibiting VEGFR2 signaling.
Guan YY; Liu HJ; Luan X; Xu JR; Lu Q; Liu YR; Gao YG; Zhao M; Chen HZ; Fang C
Phytomedicine; 2015 Jan; 22(1):103-10. PubMed ID: 25636878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
